Key facts
- This page summarizes Shawn M. Bowman's Form 4 filing for Sanara MedTech Inc. (SMTI).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Dec 2022, 17:33.
Shawn M. Bowman - 02 Dec 2022 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)
- Reporting relationship
- Pres. - Strat. Partnerships
- Issuer ticker
- SMTI
- Reported as of
- 02 Dec 2022
- Net transaction value
- -$86,767
- SEC form
- 4
- Accepted by SEC
- 06 Dec 2022, 17:33:01 UTC
- Prior SEC filing
- 26 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shawn M. Bowman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Shawn M. Bowman filed Form 4 for Sanara MedTech Inc. (SMTI) on 06 Dec 2022.
Change
- Previous filing in this sequence was filed on 26 Sep 2022.
- Current net transaction value: -$86,767.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SMTI
transaction
Common Stock
Tax liability
- Transaction value
- $37,687
- Shares
- -1,224
- Change %
- -6.6%
- Price
- $30.79
- Shares after
- 17,326
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
SMTI
transaction
Common Stock
Tax liability
- Transaction value
- $40,583
- Shares
- -1,101
- Change %
- -6.4%
- Price
- $36.86
- Shares after
- 16,225
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F2
SMTI
transaction
Common Stock
Tax liability
- Transaction value
- $2,525
- Shares
- -82
- Change %
- -0.51%
- Price
- $30.79
- Shares after
- 16,143
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F3
SMTI
transaction
Common Stock
Tax liability
- Transaction value
- $5,972
- Shares
- -260
- Change %
- -1.6%
- Price
- $22.97
- Shares after
- 15,883
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F4
SMTI
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -4,414
- Change %
- -28%
- Price
- $0.000000
- Shares after
- 11,469
- Date
- 02 Dec 2022
- Ownership
- Direct
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,022 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Footnote F2
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 4,519 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Footnote F3
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 334 shares of restricted stock granted to the reporting person on April 27, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Footnote F4
Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 1,065 shares of restricted stock granted to the reporting person on December 22, 2021. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Footnote F5
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated, and forfeited by the reporting person in connection with his resignation as President, Strategic Partnerships, effective December 2, 2022.